Advanced search

News (57)

NEC : Q&A (168KB)	05-08	PU
NEC : Q&A（276KB）	12-20	PU
NEC : Q&A (288KB)	14/08/23	PU
NEC : Notice of Resolutions adopted at the 185th Ordinary General Meeting of Shareholders (73KB)	22/06/23	PU
NEC : Q&A (276KB)	10/05/23	PU
NEC : ESG Initiatives in NEC's Purpose-Driven Management (Osamu Fujikawa,Executive Vice President and CFO,Member of the Board (Representative Director), NEC Corporation)(1,088KB)	20/04/23	PU
NEC : Q&A(399KB)	20/04/23	PU
Transcript : NEC Corporation - Special Call	28/03/23
NEC : Q&A (421KB)	09/02/23	PU
NEC : Q&A (274KB)	08/11/22	PU
NEC : Presentation（559KB）	07/09/22	PU
Q&A (Answer: Osamu Fujikawa, Executive Vice President and Chief Financial Officer (CFO))(260KB)	06/09/22	PU
NEC : Q&A (281KB)	09/08/22	PU
NEC : Notice of Resolutions adopted at the 184th Ordinary General Meeting of Shareholders	22/06/22	PU
NEC : Q&A (525KB)	09/02/22	PU
NEC : announces executive personnel changes	31/01/22	PU
NEC : Development of Robust Financial and Non-financial Measurement Methodologies for Sustainable Growth (Osamu Fujikawa, Executive Vice President and CFO)(2,126KB)	27/12/21	PU
NEC : Q&A(469KB)	20/12/21	PU
Transcript : NEC Corporation - Special Call	10/12/21
Q&A (526KB)	11/11/21	PU
CFO Message (347KB)	10/11/21	PU
Cross-Company Corporate Strategy Promotion Framework (1,063KB)	10/11/21	PU
NEC : Q&A (523KB)	13/08/21	PU
Toshiba CEO Hopes to Vote on New Board Chairman by Year-End	12/08/21	DJ
Toshiba to Appoint New Directors to Reform Corporate Governance	14/06/21	DJ
NEC : Q&A (534KB)	25/05/21	PU
NEC : announces executive personnel changes	29/01/21	PU
NEC : NanoBridge Semiconductor, Inc. secures series A financing from Japan Industrial Partners and NEC for launching full-scale business	01/12/20	PU
Transgene : NEC and BostonGene Announce Strategic Collaboration for Two Ongoing Clinical Trials for Patients with Ovarian and Head & Neck Cancers	06/10/20	AQ
NEC : Transgene, NEC and BostonGene Announce Strategic Collaboration for Two Ongoing Clinical Trials for Patients with Ovarian and Head & Neck Cancers	06/10/20	AQ
Transgene : October 6, 2020 - Transgene, NEC and BostonGene Announce Strategic Collaboration for Two Ongoing Clinical Trials for Patients with Ovarian and Head & Neck Cancers	06/10/20	PU
Transgene :, NEC and BostonGene Announce Strategic Collaboration for Two Ongoing Clinical Trials for Patients with Ovarian and Head & Neck Cancers	06/10/20	BU
NEC : BostonGene and NEC Collaborate to Analyze Cancer Patients in Clinical Trials	20/07/20	BU
NEC : and Siemens Partner to Provide AI Monitoring and Analysis Solution to Accelerate Digitization in Manufacturing	09/03/20	BU
Transgene : and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers	07/01/20	BU
NEC : and VAXIMM Announce Collaboration to Advance Personalized Neoantigen Cancer Vaccines	12/11/19	BU
VAXIMM : NEC and VAXIMM Announce Collaboration to Advance Personalized Neoantigen Cancer Vaccines	12/11/19	EQ
NEC : Acquires Norwegian Bioinformatics Company, OncoImmunity AS	29/07/19	BU
NEC : Biomedical Software Startup BostonGene Secures $50M in Series A Financing from NEC	25/04/19	BU
NEC : and Macromill launch consumer insight marketing business using AI	08/03/19	PU
Transgene : to start clinical development of lead myvacTM individualized immunotherapy, TG4050, in 2019, under its partnership with NEC	05/03/19	BU
Transgene : October 30, 2018 - NEC and Transgene announce a collaboration in the field of individualized cancer immunotherapy, leveraging NEC’s AI and Transgene’s myvac™ platform	30/10/18	PU
NEC and Transgene announce a collaboration in the field of individualized cancer immunotherapy, leveraging NEC’s AI and Transgene’s myvac™ platform	30/10/18	BU
NEC : and Transgene announce a collaboration in the field of individualized cancer immunotherapy, leveraging NEC's AI and Transgene's myvac™ platform	30/10/18	PU
NEC : and Transgene Announce a Collaboration in the Field of Individualized Cancer Immunotherapy, Leveraging NEC's AI and Transgene’s myvac™ Platform	30/10/18	BU

12NextSee all

Insiders

Osamu Fujikawa

Osamu Fujikawa currently works for NEC Corp.
as a CFO & Managing Executive Officer.

Makoto Fujikawa

Makoto Fujikawa worked as an Auditor at EDION Corp.
from 2014 to 2017.
He also worked as an Auditor at NWORK Co. Ltd.
and as an Auditor at Edion Communications Co., Ltd.
from 2014 to 2017.

Yasuo Fujikawa worked as a Managing Executive Officer at TOA Corp.
from 2013 to 2016.

No results for this search